Rising Demand For Digital And Direct Ophthalmoscopes Drives Global Expansion

Analyses DelveInsight: Ophthalmoscopes market to reach USD 294.90 million by 2034, growing at 5.24% CAGR

Published on Feb. 26, 2026

Got story updates? Submit your updates here. ›

The global ophthalmoscopes market is poised for steady and sustained growth, projected to increase from USD 187.12 million in 2025 to USD 294.90 million by 2034, expanding at a CAGR of 5.24% during 2026–2034. The market is witnessing robust momentum due to the rising prevalence of eye disorders, growing geriatric population, technological advancements in digital ophthalmoscopes, and expanding healthcare infrastructure worldwide.

Why it matters

The increasing global burden of vision-related diseases such as glaucoma, diabetic retinopathy, cataracts, and age-related macular degeneration (AMD) is significantly boosting the demand for advanced ophthalmic diagnostic devices. Technological innovation is also playing a critical role in shaping the competitive landscape of the ophthalmoscopes market, with the shift from traditional optical devices to digital ophthalmoscopes, non-mydriatic systems, LED illumination models, portable handheld devices, AI-integrated imaging tools, and scanning laser ophthalmoscopes (SLO) enhancing diagnostic accuracy and clinical efficiency.

The details

Leading ophthalmoscopes companies in the market include Baxter, HEINE Optotechnik GmbH & CO. KG, Keeler, US Ophthalmic, Rudolf Riester GmbH, Opticlar, Zumax Medical Co., Ltd., Girodmedical, Adam Rouilly Ltd., Timesco Healthcare Ltd., Zhejiang Honsun Medical Technology Co., Ltd., Iridex Corporation, NIDEK CO., Ltd., OSCAR BOSCAROL S.r.l, American Diagnostic Corporation, Lumenis Be Ltd., Veatch Ophthalmic Instruments, KIRCHNER &WILHELM GmbH + Co. KG, oDocs Eye care, Revenio Group, and others. Recent product innovations include the LYNX™ pattern scanning laser indirect ophthalmoscope from Norlase, the Eyesi Indirect Ophthalmoscope ROP simulator from Haag-Streit, and the BETA X Ophthalmoscope from HEINE Optotechnik GmbH & Co. KG.

  • In January 2025, Norlase received FDA 510(k) clearance and CE Mark approval for the LYNX™ pattern scanning laser indirect ophthalmoscope.
  • In April 2024, Haag-Streit introduced the Eyesi Indirect Ophthalmoscope ROP simulator for retinal examinations in preterm infants.
  • In April 2025, HEINE Optotechnik GmbH & Co. KG launched the BETA X Ophthalmoscope under its new X Series of handheld diagnostic instruments.

The players

Baxter

An American healthcare company that manufactures medical devices, including ophthalmoscopes.

HEINE Optotechnik GmbH & CO. KG

A German manufacturer of high-quality medical diagnostic instruments, including ophthalmoscopes.

Keeler

A British manufacturer of ophthalmic diagnostic equipment, including ophthalmoscopes.

Iridex Corporation

An American medical device company that specializes in laser-based treatments for eye diseases.

NIDEK CO., Ltd.

A Japanese manufacturer of ophthalmic diagnostic and surgical equipment, including ophthalmoscopes.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.